Löw-Baselli A et al. |
Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note. |
2000 |
Carcinogenesis |
pmid:11023545
|
Wei X et al. |
Perillyl alcohol inhibits TCR-mediated [Ca(2+)](i) signaling, alters cell shape and motility, and induces apoptosis in T lymphocytes. |
2000 |
Cell. Immunol. |
pmid:10805968
|
Chaudhary SC et al. |
Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis. |
2009 |
Chem. Biol. Interact. |
pmid:19161993
|
Miyazawa M et al. |
Sex differences in the metabolism of (+)- and (-)-limonene enantiomers to carveol and perillyl alcohol derivatives by cytochrome p450 enzymes in rat liver microsomes. |
2002 |
Chem. Res. Toxicol. |
pmid:11800592
|
Seifert A et al. |
An efficient route to selective bio-oxidation catalysts: an iterative approach comprising modeling, diversification, and screening, based on CYP102A1. |
2011 |
Chembiochem |
pmid:21591046
|
Gómez-Contreras PC et al. |
In vitro induction of apoptosis in U937 cells by perillyl alcohol with sensitization by pentoxifylline: increased BCL-2 and BAX protein expression. |
2006 |
Chemotherapy |
pmid:17008791
|
Stearns V et al. |
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. |
2004 |
Clin. Cancer Res. |
pmid:15569989
|
Ripple GH et al. |
Phase I clinical trial of perillyl alcohol administered daily. |
1998 |
Clin. Cancer Res. |
pmid:9607573
|
Hudes GR et al. |
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. |
2000 |
Clin. Cancer Res. |
pmid:10955786
|
Ripple GH et al. |
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. |
2000 |
Clin. Cancer Res. |
pmid:10690515
|